The Metacognition Assessment Scale (MAS-A): Results of a Pilot Study Applying a German Translation to Individuals with Schizophrenia Spectrum Disorders
Overview
Authors
Affiliations
Objectives: Metacognition, the capacity 'to think about thinking' and thus to reflect and to master interpersonal problems on a mentalistic basis, is often impaired among patients with schizophrenia spectrum disorders and has been suggested as a potential treatment target. However, little is known about the reliability of its measurement and links with related phenomena. The aim of this study was to validate a German translation of the Metacognition Assessment Scale (MAS-A) as a measure to assess metacognition from free narratives of patients' personally relevant episodes and relationships.
Design And Methods: MAS-A was applied to narratives of 22 individuals with schizophrenia spectrum disorders together with self-ratings and behavioural tests of metacognitive and related functions such as mentalizing and emotional awareness. Multi-level modelling allowed to calculate inter-rater reliability (IRR) and inter-rater agreement (IRA) and to include test results as level-2 predictors of the aggregated scorings on the MAS-A subscales in order to explore convergent validity. After considering neurocognition and symptom scores as further predictors, aggregated scorings were correlated with psychosocial functioning.
Results: There were high IRRs and IRAs all over the ratings. None of the related measures accounted for variance in MAS-A scorings, indicating the existence of separable, non-overlapping constructs. Verbal memory and positive symptoms were significant predictors for MAS-A subscales. MAS-A, but no other measure, displayed significant associations with psychosocial functioning.
Conclusions: MAS-A is a reliable expert rating to assess metacognition from patients' free narratives. Considering the link to psychosocial functioning, MAS-A appears to be a promising tool for the evaluation of metacognition.
Practitioner Points: MAS-A is a reliable tool to evaluate metacognitive function from narratives about emotionally relevant topics and meaningful relationships. Metacognition appears separate from neighbouring constructs such as mentalizing, ToM, or emotional awareness. MAS-A scales are significantly predicted by verbal memory and positive symptoms. Only MAS-A scales display significant associations with psychosocial functioning, and it thus is a promising tool to evaluate metacognition in psychotherapy research.
Kilicoglu M, Lundin N, Angers K, Moe A Behav Sci (Basel). 2024; 14(4).
PMID: 38667061 PMC: 11047350. DOI: 10.3390/bs14040265.
Montemagni C, Brasso C, Bellino S, Bozzatello P, Villari V, Rocca P Front Psychiatry. 2024; 14:1278113.
PMID: 38179251 PMC: 10765532. DOI: 10.3389/fpsyt.2023.1278113.
Metacognition in Schizophrenia Spectrum Disorders-Current Methods and Approaches.
Lungu P, Lungu C, Ciobica A, Balmus I, Bolos A, Dobrin R Brain Sci. 2023; 13(7).
PMID: 37508936 PMC: 10377717. DOI: 10.3390/brainsci13071004.
Cheli S, Cavalletti V, Lysaker P, Dimaggio G, Petrocchi N, Chiarello F BMC Psychiatry. 2023; 23(1):113.
PMID: 36803673 PMC: 9942388. DOI: 10.1186/s12888-023-04610-5.
Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders.
Maassen E, Buttner M, Brocker A, Stuke F, Bayer S, Hadzibegovic J Front Psychol. 2021; 12:725787.
PMID: 34858263 PMC: 8632138. DOI: 10.3389/fpsyg.2021.725787.